{
  "symbol": "IPHA",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["Biotechnology sector", "Small market capitalization", "Phase II and III clinical trials"],
    "riskScore": 7,
    "reason": "Innate Pharma operates in the biotechnology sector, which is prone to speculation, and has a small market cap, making it susceptible to retail-driven price movements."
  }
}